NOVA1 (NOVA alternative splicing regulator 1)

2003-06-01  

Identity

HGNC
LOCATION
14q12
LOCUSID
ALIAS
Nova-1
FUSION GENES

Other Information

Locus ID:

NCBI: 4857
MIM: 602157
HGNC: 7886
Ensembl: ENSG00000139910

Variants:

dbSNP: 4857
ClinVar: 4857
TCGA: ENSG00000139910
COSMIC: NOVA1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000139910ENST00000344429P51513
ENSG00000139910ENST00000347476G8JLA5
ENSG00000139910ENST00000449198J3KQU3
ENSG00000139910ENST00000465357P51513
ENSG00000139910ENST00000483536F8VYI3
ENSG00000139910ENST00000539517P51513
ENSG00000139910ENST00000546546H0YHZ1
ENSG00000139910ENST00000547619F8W659
ENSG00000139910ENST00000549146F8VW64
ENSG00000139910ENST00000549571F8VWX1
ENSG00000139910ENST00000574031I3L2B5

Expression (GTEx)

0
10
20
30
40
50
60

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
378162582024RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA.0
384166792024NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.1
386570942024Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.0
378162582024RNA-binding protein NOVA1 promotes acute T-lymphocyte leukemia progression by stabilizing USP44 mRNA.0
384166792024NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells.1
386570942024Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.0
358823612023Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors.7
372467062023NOVA1 prevents overactivation of the unfolded protein response and facilitates chromatin access during human white adipogenesis.1
377753152023Pattern of Brain Parenchymal Damage Related to Cerebral Small Vessel Disease in Carriers of Rare NOTCH3 Variants.0
378873202023Interaction of the C9orf72-Amyotrophic Lateral Sclerosis-Related Proline-Arginine Dipeptide Repeat Protein with the RNA-Binding Protein NOVA1 Causes Decreased Expression of UNC13A Due to Enhanced Inclusion of Cryptic Exons, Which Is Reversed by Betulin Treatment.0
358823612023Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors.7
372467062023NOVA1 prevents overactivation of the unfolded protein response and facilitates chromatin access during human white adipogenesis.1
377753152023Pattern of Brain Parenchymal Damage Related to Cerebral Small Vessel Disease in Carriers of Rare NOTCH3 Variants.0
378873202023Interaction of the C9orf72-Amyotrophic Lateral Sclerosis-Related Proline-Arginine Dipeptide Repeat Protein with the RNA-Binding Protein NOVA1 Causes Decreased Expression of UNC13A Due to Enhanced Inclusion of Cryptic Exons, Which Is Reversed by Betulin Treatment.0
357785672022Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis.9

Citation

Dessen P

NOVA1 (NOVA alternative splicing regulator 1)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/41560/case-report-explorer/teaching-explorer/js/lib/all.min.js